These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 16763249)
1. Diagnosis and management of thyrotoxicosis. Pearce EN BMJ; 2006 Jun; 332(7554):1369-73. PubMed ID: 16763249 [No Abstract] [Full Text] [Related]
2. Managing thyrotoxicosis in the acute medical setting. Napier C Acute Med; 2018; 17(1):44-48. PubMed ID: 29589605 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of thyrotoxicosis. Vaidya B; Pearce SH BMJ; 2014 Aug; 349():g5128. PubMed ID: 25146390 [No Abstract] [Full Text] [Related]
4. [The diagnosis and treatment of diffuse toxic goiter (a lecture)]. Petunina NA; Balabolkin MI Ter Arkh; 1997; 69(10):12-7. PubMed ID: 9471780 [No Abstract] [Full Text] [Related]
5. Treatment of post-partum thyrotoxicosis. Azizi F J Endocrinol Invest; 2006 Mar; 29(3):244-7. PubMed ID: 16682838 [TBL] [Abstract][Full Text] [Related]
6. Clinical approach to thyrotoxicosis. Issa BG; Hanna FW Practitioner; 2004 May; 248(1658):358-61. PubMed ID: 15160477 [No Abstract] [Full Text] [Related]
7. Thyrotoxicosis and pulmonary hypertension. Ma RC; Cheng AY; So WY; Hui DS; Tong PC; Chow CC Am J Med; 2005 Aug; 118(8):927-8. PubMed ID: 16084191 [No Abstract] [Full Text] [Related]
8. Evaluating and managing patients with thyrotoxicosis. Campbell K; Doogue M Aust Fam Physician; 2012 Aug; 41(8):564-72. PubMed ID: 23145395 [TBL] [Abstract][Full Text] [Related]
9. Management of thyrotoxicosis. Fisher JN South Med J; 2002 May; 95(5):493-505. PubMed ID: 12005006 [No Abstract] [Full Text] [Related]
10. Evaluation and Management of Children with Thyrotoxicosis. Leung AKC; Leung AAC Recent Pat Endocr Metab Immune Drug Discov; 2017; 11(1):22-31. PubMed ID: 29589552 [TBL] [Abstract][Full Text] [Related]
11. Hyperthyroidism: A Review. Lee SY; Pearce EN JAMA; 2023 Oct; 330(15):1472-1483. PubMed ID: 37847271 [TBL] [Abstract][Full Text] [Related]
13. Thyrotoxicosis. Results and risks of current therapy. de los Santos ET; Mazzaferri EL Postgrad Med; 1990 Apr; 87(5):277-8, 281-6, 291-4. PubMed ID: 1690882 [TBL] [Abstract][Full Text] [Related]
14. [Antithyroid and TSH-suppressive treatment in Basedow disease?]. Mann K; Hörmann R Internist (Berl); 1998 Jun; 39(6):610-2. PubMed ID: 9677519 [No Abstract] [Full Text] [Related]
17. Etiology and outcome of thyrotoxicosis at a university hospital. Akbar DH; Mushtaq MM; Al-Sheik AA Saudi Med J; 2000 Apr; 21(4):352-4. PubMed ID: 11533817 [TBL] [Abstract][Full Text] [Related]
18. Graves' disease. Weetman AP N Engl J Med; 2000 Oct; 343(17):1236-48. PubMed ID: 11071676 [No Abstract] [Full Text] [Related]
20. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease. Izumi Y; Takeoka K; Amino N Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]